期刊文献+

MODY2的认识及诊疗进展 被引量:4

The cognition, diagnosis and treatment of MODY2
原文传递
导出
摘要 青少年发病的成年型糖尿病2型(MODY2)由葡萄糖激酶(GCK)基因突变所致,以空腹血糖及糖化血红蛋白水平轻度升高并保持稳定状态为主要表现,多不增加糖尿病并发症及相关代谢疾病的发生风险,无需降糖治疗。但对于妊娠期患者,若胎儿未携带突变基因,妊娠相关并发症及巨大儿发生风险增加,故此类患者需积极降糖治疗。 Maturity-onset diabetes of the young (MODY) caused by glucokinase (GCK) gene mu- tation is called MODY2. Previous study has demonstrated that the levels of fasting blood glucose and glycated hemoglobin (HbAlc) in MODY2 increase slightly and keep stable. It will not raise the incidence of compli- cations of diabetes and other related metabolic disease. Accordingly, there is no need to give treatment. But for pregnant women, if the fetus is without GCK gene mutation, the risk of macrosomia and perinatal morbidi- ty will increase. Therefore, it is necessary to lower the level of blood glucose.
作者 周庆菊 李蓉
出处 《国际内分泌代谢杂志》 2016年第3期180-183,共4页 International Journal of Endocrinology and Metabolism
基金 国家临床重点专科建设项目(2011)
关键词 青少年发病的成年型糖尿病2型 糖尿病 葡萄糖激酶 基因突变 Maturity-onset diabetes of the young 2 Diabetes mellitus Glucokiuase Gene mutation
  • 相关文献

参考文献21

二级参考文献86

  • 1Sagen JV, Odili S, Bjorkhaug L, et al. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation . Diabetes, 2006,55 (6) : 1713-1722.
  • 2Futamura M, Hosaka H, Kadotani A, et al. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism. J Biol Chem, 2006, 281 (49) :37668-37674.
  • 3Froguel PH, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature, 1992,356 (6365) : 162-164.
  • 4Matschinsky FM. Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diabetes Rep, 2005,5 (3):171-176.
  • 5Alvarez E, Roncero I, Chowen JA, et al. Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem, 2002 , 80 ( 1 ) : 45- 53.
  • 6Christesen HB, Jacobsen BB, Odili S, et al. The second activating glucokinase mutation (A456V) : implications for glucose homeostasis and diabetes therapy . Diabetes, 2002, 51 (4) :1240-1246.
  • 7Cuesta-Munoz AL, Huopio H, Otonkoski T, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes, 2004, 53 (8) :2164-2168.
  • 8Gloyn AL, Noordam K, Willemsen MA, et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes, 2003, 52(9) :2433-2440.
  • 9Njolstad PR, Sovik O, Cuesta-Munoz A, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency . N Engl J Med, 2001, 344(21) :1588-1592.
  • 10Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent neonatal diabetes mellitus caused by glucokinase deficiency:inborn error of the glucose-insulin signaling pathway . Diabetes,2003, 52( 11 ) :2854-2860.

共引文献33

同被引文献17

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部